Рет қаралды 208
Dr. Paulus Kirchhof discusses edoxaban vs placebo to prevent strokes or CV events in patients with atrial high rate episodes.
Learn about the NOAF-AFNET 6 trial unveiled during the European Society of Cardiology Congress 2023👉cardiology-update.com
#esc2023 #esccongress #cardiologist #cardiology #cardiologyupdate